A next-generation vaccine that uses a weakened form of a malaria parasite has shown efficacy and safety in a small number of humans, according to a new study published in Science Translational Medicine.
Ujunwa Atueyi
Advertisement
The News You Need, Delivered To You.
Subscribe to the Guardian today and never miss the stories that shape your Business